In recent years, a number of studies have demonstrated that radiomics is regarded as an useful and noninvasive method for predicting the Ki-67 status in patients with BC, however, most of the studies are on the basis of mammography and MRI imaging (16, 17, 27–29). This evidence concerns the gene MKI67 and breast cancer.